Difficulty: Medium
Average Score: 81%
Practice
All of the following agents have been used in drug regimens for the treatment of breast carcinoma. Which one has specific activity in a subset of female breast cancers?
Correct answer
D
Rationale
The correct answer is D) Trastuzumab. Trastuzumab is a targeted therapy that specifically targets the HER2 protein, which is overexpressed in about 20-25% of breast cancers. It is used in the treatment of HER2-positive breast cancers, making it effective in a subset of female breast cancers.
A) Anastrozole is an aromatase inhibitor used in hormone receptor-positive breast cancer, not specific to a subset like HER2-positive cancers.
B) Doxorubicin is a chemotherapy drug used in a variety of cancers but does not have specific activity in a subset of female breast cancers like Trastuzumab.
C) Fluoxymesterone is an androgen and anabolic steroid, not typically used in breast cancer treatment.
Educationally, understanding targeted therapies like Trastuzumab and their specific mechanisms of action is crucial for nurses and healthcare professionals caring for patients with breast cancer. Knowing the specific indications for each chemotherapy drug helps in providing personalized and effective care for patients undergoing cancer treatment.
A) Anastrozole is an aromatase inhibitor used in hormone receptor-positive breast cancer, not specific to a subset like HER2-positive cancers.
B) Doxorubicin is a chemotherapy drug used in a variety of cancers but does not have specific activity in a subset of female breast cancers like Trastuzumab.
C) Fluoxymesterone is an androgen and anabolic steroid, not typically used in breast cancer treatment.
Educationally, understanding targeted therapies like Trastuzumab and their specific mechanisms of action is crucial for nurses and healthcare professionals caring for patients with breast cancer. Knowing the specific indications for each chemotherapy drug helps in providing personalized and effective care for patients undergoing cancer treatment.